Hao Deng

907 total citations
71 papers, 635 citations indexed

About

Hao Deng is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Hao Deng has authored 71 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 23 papers in Molecular Biology and 15 papers in Surgery. Recurrent topics in Hao Deng's work include Cytokine Signaling Pathways and Interactions (7 papers), Estrogen and related hormone effects (6 papers) and Virus-based gene therapy research (4 papers). Hao Deng is often cited by papers focused on Cytokine Signaling Pathways and Interactions (7 papers), Estrogen and related hormone effects (6 papers) and Virus-based gene therapy research (4 papers). Hao Deng collaborates with scholars based in China, United States and Hong Kong. Hao Deng's co-authors include Zhaoyi Wang, Xintian Zhang, Zhe‐Shan Quan, Qing‐Kun Shen, Ping Chen, Jiang Cao, Lisa M.J. Lee, Zoran Gatalica, Lìjiāng Liú and Hongyan Guo and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Hao Deng

64 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hao Deng China 16 277 162 149 108 60 71 635
Suresh Guruswamy United States 11 411 1.5× 140 0.9× 110 0.7× 54 0.5× 42 0.7× 16 608
Yusuke Nakamura Japan 13 414 1.5× 179 1.1× 71 0.5× 61 0.6× 66 1.1× 38 734
Ekaterina A. Lesovaya Russia 14 326 1.2× 123 0.8× 101 0.7× 71 0.7× 21 0.3× 64 600
Rodrigo Esaki Tamura Brazil 12 445 1.6× 181 1.1× 124 0.8× 142 1.3× 115 1.9× 33 783
Y C Wong Hong Kong 13 385 1.4× 223 1.4× 71 0.5× 165 1.5× 38 0.6× 14 681
Shelley J. Edmunds New Zealand 13 486 1.8× 176 1.1× 90 0.6× 216 2.0× 49 0.8× 15 759
Aaron M. Sargeant United States 18 472 1.7× 130 0.8× 93 0.6× 130 1.2× 79 1.3× 30 819
Sunali Mehta New Zealand 17 431 1.6× 224 1.4× 67 0.4× 188 1.7× 40 0.7× 39 772
Khurum Khan United Kingdom 10 289 1.0× 226 1.4× 55 0.4× 128 1.2× 67 1.1× 28 567
John G. Shelton United States 14 638 2.3× 267 1.6× 70 0.5× 102 0.9× 54 0.9× 17 929

Countries citing papers authored by Hao Deng

Since Specialization
Citations

This map shows the geographic impact of Hao Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Deng more than expected).

Fields of papers citing papers by Hao Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Deng. The network helps show where Hao Deng may publish in the future.

Co-authorship network of co-authors of Hao Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Hao Deng. A scholar is included among the top collaborators of Hao Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao Deng. Hao Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Deng, Hao, Qian Xu, Guoqing Chen, et al.. (2025). Design and synthesis of azole derivatives of echinocystic acid as α-glucosidase inhibitors with hypoglycemic activity. European Journal of Medicinal Chemistry. 289. 117437–117437. 1 indexed citations
3.
Wang, Shiyan, et al.. (2025). Initial experience of single-incision robotic surgery for lateral suspension of patients with pelvic organ prolapse. SHILAP Revista de lepidopterología. 8. 8–13.
4.
Shao, Fang, Hao Deng, Wei Zhang, et al.. (2024). The increase of long noncoding RNA Fendrr in hepatocytes contributes to liver fibrosis by promoting IL-6 production. Journal of Biological Chemistry. 300(6). 107376–107376. 5 indexed citations
5.
6.
Xu, Qian, Hao Deng, Xing Huang, et al.. (2024). Design, synthesis, and in vitro and in vivo biological evaluation of dihydroartemisinin derivatives as potent anti-cancer agents with ferroptosis-inducing and apoptosis-activating properties. European Journal of Medicinal Chemistry. 281. 117018–117018. 4 indexed citations
7.
Wang, Zhiqi, Hao Deng, Guo Zhang, et al.. (2023). Comparison of sentinel lymph node distribution and lymphatic drainage pathway between high- and low-risk endometrial cancers. Archives of Gynecology and Obstetrics. 308(5). 1641–1647. 2 indexed citations
8.
Shao, Fang, Hao Deng, Wei Zhang, et al.. (2023). Loss of EGFR contributes to high‐fat diet‐induced nonalcoholic fatty liver disease. FEBS Letters. 597(11). 1503–1516. 13 indexed citations
9.
Chen, Jialing, et al.. (2022). Development of a RPA-CRISPR-Cas12a Assay for Rapid, Simple, and Sensitive Detection of Mycoplasma hominis. Frontiers in Microbiology. 13. 842415–842415. 23 indexed citations
10.
Huang, Xing, Lili Jin, Hao Deng, et al.. (2022). Research and Development of Natural Product Tanshinone I: Pharmacology, Total Synthesis, and Structure Modifications. Frontiers in Pharmacology. 13. 920411–920411. 19 indexed citations
11.
Chen, Jialing, Hao Deng, Hongfeng Wu, et al.. (2022). Preclinical efficacy and involvement of mTOR signaling in the mechanism of Orf virus against nasopharyngeal carcinoma cells. Life Sciences. 291. 120297–120297. 6 indexed citations
12.
Deng, Hao, et al.. (2022). Study on the vasodilatory activity of lotus leaf extract and its representative substance nuciferine on thoracic aorta in rats. Frontiers in Pharmacology. 13. 946445–946445. 3 indexed citations
13.
Wang, Jing, Xia Yang, Peng Zhao, et al.. (2021). Investigating Antibacterial Efficiency and Mechanism of Oligo-thiophenes under White Light and Specific Biocidal Activity against E. coli in Dark. ACS Applied Bio Materials. 4(4). 3561–3570. 3 indexed citations
14.
Fan, Yuan, Hao Deng, Li Tian, & Jianliu Wang. (2021). Cutaneous metastases of endometrial carcinoma: report of an unusual case and literature review. Archives of Gynecology and Obstetrics. 304(5). 1127–1133. 3 indexed citations
15.
Wang, Rending, et al.. (2020). ABO‐incompatible living kidney transplantation. Clinical Transplantation. 34(9). e14050–e14050. 7 indexed citations
16.
Deng, Hao, et al.. (2019). Synthesis, in vitro and in vivo biological evaluation of dihydroartemisinin derivatives with potential anti-Toxoplasma gondii agents. Bioorganic Chemistry. 94. 103467–103467. 21 indexed citations
17.
Chen, Chun-Ye, Feng Yan, Jingyu Chen, & Hao Deng. (2015). Identification of a potent inhibitor targeting human lactate dehydrogenase A and its metabolic modulation for cancer cell line. Bioorganic & Medicinal Chemistry Letters. 26(1). 72–75. 16 indexed citations
18.
Deng, Hao, Li Yin, Xintian Zhang, et al.. (2014). ER-α variant ER-α36 mediates antiestrogen resistance in ER-positive breast cancer stem/progenitor cells. The Journal of Steroid Biochemistry and Molecular Biology. 144. 417–426. 31 indexed citations
19.
Tan, Jiaxin, Yu You, Yu Peng, et al.. (2013). Par-4 downregulation confers cisplatin resistance in pancreatic cancer cells via PI3K/Akt pathway-dependent EMT. Toxicology Letters. 224(1). 7–15. 33 indexed citations
20.
Deng, Hao, et al.. (2011). The antagonistic effect between STAT1 and Survivin and its clinical significance in gastric cancer. Oncology Letters. 3(1). 193–199. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suresh Guruswamy Breakdown of academic impact, for papers by Yusuke Nakamura Breakdown of academic impact, for papers by Ekaterina A. Lesovaya Breakdown of academic impact, for papers by Rodrigo Esaki Tamura Breakdown of academic impact, for papers by Y C Wong Breakdown of academic impact, for papers by Shelley J. Edmunds Breakdown of academic impact, for papers by Aaron M. Sargeant Breakdown of academic impact, for papers by Sunali Mehta Breakdown of academic impact, for papers by Khurum Khan Breakdown of academic impact, for papers by John G. Shelton
Rankless by CCL
2026